• Loading stock data...
Est. 2004

Thursday 03/7/2019

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More


  • 2:55 PM

    Results Include 29% Growth in Sales and Net Income of $1.6 Million SAN DIEGO, CA–(Marketwired – September 29, 2016) – Franklin Wireless Corp. (OTCQB: FKWL), a market leader in broadband data communications including hardware and software solutions for M2M and the IoT (Internet of Things), today announced full-year financial results for the fiscal year ended June 30, 2016. The Company reported net sales for fiscal 2016 of $59.8 million, compared with $46.3 million in net sales for fiscal 2015. The

    Read more
  • 2:18 PM

    Company Signs Third Major Contract in 2016, Totaling More Than $150 Million in Revenue NAPLES, FL— FTNW, (Marketwired – April 13, 2016) – FTE Networks, Inc. (OTCQB: FTNW) (“FTE” or the “Company”), a leading networking infrastructure service solutions provider in the technology and telecommunications vertical, announced today that it has been awarded a multi-year contract with a leading telecommunications carrier valued up to $8 million. This additional contract began on April 1, 2016 and will continue over the next three years.

    Read more
  • 5:51 PM

    OXFORD, Connecticut, January 8, 2016, NXTD, /PRNewswire/ — Nxt-ID, Inc. (NASDAQ: NXTD), a company focused on the growing m-commerce market and WorldVentures®, a privately held leading direct seller of vacation and entertainment club memberships and an Inc. 5000 fastest-growing company announced that on December 31, 2015, that WorldVentures completed a strategic investment of $2 million in Nxt-ID to develop a proprietary new wireless smart card for its members based on Nxt-ID’s Wocket®, a unique smart wallet that serves to securely

    Read more
  • 3:50 PM

    ORLANDO, FL, IMUN, / ACCESSWIRE/ Immune Therapeutics Inc. a specialty biopharmaceutical company (OTCQB: IMUN) today provided an update on the ongoing clinical trial of Lodonal in Nigeria. The trial is an open-label, placebo-controlled study that includes a 90-day treatment period followed by a 60-day extension. The primary objective of this clinical trial is to confirm that Lodonal has a beneficial effect on the immune system of patients in Nigeria with a compromised immune system (refer to Inclusion/Exclusion Criteria). This will

    Read more
  • 3:50 PM

    PRINCETON, N.J., Dec. 9, 2015, SNGX, /PRNewswire/ — Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has recently received approximately $490,000, net of transaction costs, in non-dilutive financing via the state of New Jersey’s Technology Business Tax Certificate Transfer Program (the Program). This Program enables approved, unprofitable biotechnology businesses to sell their unused Net Operating

    Read more
  • 2:27 PM

    Sep 25, 2015 OTC Disclosure & News Service – FLEMINGTON, N.J., Sept. 25, 2015, OTCQB, ARNI, (GLOBE NEWSWIRE) — Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of therapeutics for cancer and other life threatening diseases, today announced that a late-breaking abstract on AR-12 has been accepted for poster presentation at the upcoming 15th European AIDS Conference, hosted by the European AIDS Clinical Society (EACS) and being held October 21-24 in Barcelona, Spain. Logistical details

    Read more
Public Wire Banner